Testing naltrexone to prevent overdose in stimulant users
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at risk for HIV or currently living with HIV.
- You have a stimulant use disorder or have tested positive for cocaine, amphetamine, or methamphetamine in the last 6 months and use stimulants at least 10 days per month.
- You are 18 years or older.
- You can speak English and give informed consent.
- You must not be using opioids (prescribed or non-prescribed) or have opioid use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of buprenorphine (through your care plan) and a monthly extended-release naltrexone (XR-NTX) shot can help prevent opioid relapse. It may help people who are ready to move toward a naltrexone-based relapse-prevention treatment after detox.
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
This study tests a long-acting implant that releases naltrexone slowly over time to help prevent relapse in people with opioid use disorder. The implant is placed under the skin in a minor procedure and may help you stay opioid-free.
This study tests whether the medication naltrexone can help reduce self-harm urges or actions in people who hurt themselves without intending suicide. It may offer a new option if current treatments haven't been enough.
This study tests whether a medication called naltrexone can help reduce the urge or behavior of self-injury (hurting yourself on purpose) in people who have not improved with standard treatment. It may offer a new option to manage these urges.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
Hear when a new Overdose Accidental trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.